Mumbai, India , is rapidly emerging as a vital hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established strong manufacturing plants focusing on this critical antiviral medicine . Identifying the definitive top manufacturers can be challenging due to fluctuating market dynamics, but reputable names often